Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy
- PMID: 19414560
- PMCID: PMC2845314
- DOI: 10.1177/1049909109335146
Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy
Abstract
To assess the role of biopsychosocial factors in patients with type 1 myotonic and facioscapulohumeral muscular dystrophy (MMD1/FSHD) with chronic pain. Associations between psychosocial factors were found to be important in other samples of persons with pain and both psychological functioning and pain interference in a sample of patients suffering from MMD/FSHD. Prospective, multiple group, survey study of 182 patients with confirmed MMD1 and FSHD. Participants completed surveys assessing pain interference and psychological functioning, as well as psychosocial, demographic, and injury-related variables. Analyses indicated that greater catastrophizing was associated with increased pain interference and poorer psychological functioning, pain attitudes were significantly related to both pain interference and psychological functioning, and coping responses were significantly related only to pain interference. In addition, greater perceived social support was associated with better psychological functioning. The results support the use of studying pain in persons with MMD/FSHD from a biopsychosocial perspective, and the importance of identifying psychosocial factors that may play a role in the adjustment to and response to pain secondary to MMD/FSHD.
Similar articles
-
Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy.Clin J Pain. 2012 Jan;28(1):47-54. doi: 10.1097/AJP.0b013e31822019b1. Clin J Pain. 2012. PMID: 21642844 Free PMC article.
-
Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.Arch Phys Med Rehabil. 2008 Feb;89(2):320-8. doi: 10.1016/j.apmr.2007.08.153. Arch Phys Med Rehabil. 2008. PMID: 18226657 Free PMC article.
-
Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.Am J Phys Med Rehabil. 2014 May;93(5):387-95. doi: 10.1097/PHM.0000000000000032. Am J Phys Med Rehabil. 2014. PMID: 24247759 Free PMC article.
-
Psychosocial functioning in patients with altered facial expression: a scoping review in five neurological diseases.Disabil Rehabil. 2024 Aug;46(17):3772-3791. doi: 10.1080/09638288.2023.2259310. Epub 2023 Sep 26. Disabil Rehabil. 2024. PMID: 37752723
-
Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases.J Neuromuscul Dis. 2024;11(3):535-565. doi: 10.3233/JND-230213. J Neuromuscul Dis. 2024. PMID: 38517799 Free PMC article.
Cited by
-
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).Neurology. 2015 Dec 15;85(24):2136-46. doi: 10.1212/WNL.0000000000002225. Epub 2015 Nov 18. Neurology. 2015. PMID: 26581301 Free PMC article.
-
The relationship between PTSD and chronic pain: mediating role of coping strategies and depression.Pain. 2013 Apr;154(4):609-616. doi: 10.1016/j.pain.2013.01.001. Epub 2013 Jan 11. Pain. 2013. PMID: 23398939 Free PMC article.
-
Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy.Clin J Pain. 2012 Jan;28(1):47-54. doi: 10.1097/AJP.0b013e31822019b1. Clin J Pain. 2012. PMID: 21642844 Free PMC article.
-
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).Neurology. 2019 Sep 17;93(12):e1180-e1192. doi: 10.1212/WNL.0000000000008123. Epub 2019 Aug 13. Neurology. 2019. PMID: 31409737 Free PMC article.
-
A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.J Neuromuscul Dis. 2018;5(3):279-294. doi: 10.3233/JND-180310. J Neuromuscul Dis. 2018. PMID: 30040740 Free PMC article. Review.
References
-
- Johnson ER, Carter GT, Kilmer DD, et al. Profiles of neuromuscular disease: myotonic muscular dystrophy. Am J Phys Med Rehabil. 1995;74(5):S104–S116. - PubMed
-
- Kilmer DD, Abresch RT, Aitkens SG, et al. Profiles of neuromuscular disease: facioscapulohumeral dystrophy. Am J Phys Med Rehabil. 1995;74(5):S131–S139. - PubMed
-
- Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol. 2007;20(5):572–576. - PubMed
-
- Feyma T, Carter GT, Weiss MD. Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma. Muscle Nerve. 2008;38(1):916–920. - PubMed
-
- McDonald CM, Han JJ, Carter GT. Myopathic Disorders. In: Braddom RL, editor. Physical Medicine and Rehabilitation. 3. Philadelphia, PA: WB Saunders/Elsevier; 2007. pp. 1099–1131.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical